Stratos Wealth Advisors LLC decreased its position in Colgate-Palmolive (NYSE:CL – Free Report) by 18.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,400 shares of the company’s stock after selling 1,222 shares during the period. Stratos Wealth Advisors LLC’s holdings in Colgate-Palmolive were worth $491,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Union Bancaire Privee UBP SA bought a new position in Colgate-Palmolive during the 4th quarter valued at about $32,000. Reston Wealth Management LLC bought a new position in shares of Colgate-Palmolive in the 3rd quarter worth approximately $42,000. Synergy Asset Management LLC bought a new position in shares of Colgate-Palmolive in the 4th quarter worth approximately $49,000. Capital Performance Advisors LLP bought a new position in shares of Colgate-Palmolive in the 3rd quarter worth approximately $53,000. Finally, Prospera Private Wealth LLC bought a new position in shares of Colgate-Palmolive in the 3rd quarter worth approximately $64,000. Institutional investors own 80.41% of the company’s stock.
Analyst Ratings Changes
Several equities analysts have recently weighed in on the stock. Raymond James reiterated an “outperform” rating and issued a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Piper Sandler reduced their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. UBS Group reduced their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a report on Monday, February 3rd. Wells Fargo & Company reduced their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. Finally, Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 target price on shares of Colgate-Palmolive in a report on Wednesday, January 29th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $101.16.
Colgate-Palmolive Stock Up 1.3 %
NYSE:CL opened at $86.81 on Friday. Colgate-Palmolive has a twelve month low of $82.68 and a twelve month high of $109.30. The company has a market cap of $70.93 billion, a price-to-earnings ratio of 24.66, a price-to-earnings-growth ratio of 3.61 and a beta of 0.44. The stock has a fifty day simple moving average of $90.56 and a 200-day simple moving average of $96.84. The company has a current ratio of 0.41, a quick ratio of 0.26 and a debt-to-equity ratio of 9.46.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the business earned $0.87 earnings per share. Analysts anticipate that Colgate-Palmolive will post 3.74 EPS for the current year.
Colgate-Palmolive Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.30%. Colgate-Palmolive’s dividend payout ratio is currently 56.82%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- The 3 Best Blue-Chip Stocks to Buy Now
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- How to Invest in the FAANG Stocks
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.